These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 15282402)

  • 1. Oral and dermal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces cutaneous papillomas and squamous cell carcinomas in female hemizygous Tg.AC transgenic mice.
    Wyde ME; Braen AP; Hejtmancik M; Johnson JD; Toft JD; Blake JC; Cooper SD; Mahler J; Vallant M; Bucher JR; Walker NJ
    Toxicol Sci; 2004 Nov; 82(1):34-45. PubMed ID: 15282402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicology and carcinogenesis studies of pyrogallol (CAS No. 87-66-1) in F344/N rats and B6C3F1/N mice (dermal studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2013 Feb; (574):1-167. PubMed ID: 23518671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical analysis of skin tumor data from Tg.AC mouse bioassays.
    Dunson DB; Haseman JK; van Birgelen AP; Stasiewicz S; Tennant RW
    Toxicol Sci; 2000 Jun; 55(2):293-302. PubMed ID: 10828260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative toxicity and tumor-promoting ability of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), 2,3,4,7,8-pentachlorodibenzofuran (PCDF), and 1,2,3,4,7,8-hexachlorodibenzofuran (HCDF) in hairless mice.
    Hébert CD; Harris MW; Elwell MR; Birnbaum LS
    Toxicol Appl Pharmacol; 1990 Feb; 102(2):362-77. PubMed ID: 2300974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemizygous Tg.AC transgenic mouse as a potential alternative to the two-year mouse carcinogenicity bioassay: evaluation of husbandry and housing factors.
    Holden HE; Stoll RE; Spalding JW; Tennant RW
    J Appl Toxicol; 1998; 18(1):19-24. PubMed ID: 9526830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicology and carcinogenesis studies of 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Sep; (525):1-198. PubMed ID: 17160103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of SEPA 0009-induced tumorigenesis in v-rasHa transgenic Tg.AC mice.
    Fuhrman J; Shafer L; Repertinger S; Chan T; Hansen LA
    Toxicol Pathol; 2005; 33(6):623-30. PubMed ID: 16176921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the carcinogenic potential of clofibrate in the FVB/Tg.AC mouse after dermal application--part II.
    Torrey CE; Wall HG; Campbell JA; Kwanyuen P; Hoivik DJ; Miller RT; Allen JS; Jayo MJ; Selinger K; Santostefano MJ
    Int J Toxicol; 2005; 24(5):327-39. PubMed ID: 16257852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxymetholone: II. Evaluation in the Tg-AC transgenic mouse model for detection of carcinogens.
    Holden HE; Stoll RE; Blanchard KT
    Toxicol Pathol; 1999; 27(5):507-12. PubMed ID: 10528629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Tg.AC assay: specificity testing with three noncarcinogenic pharmaceuticals that induce selected stress gene promoters in vitro and the inhibitory effects of solvent components.
    Thompson KL; Rosenzweig BA; Weaver JL; Zhang J; Lin KK; Sistare FD
    Toxicol Sci; 2003 Aug; 74(2):271-8. PubMed ID: 12773758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tg.AC genetically altered mouse: assay working group overview of available data.
    Eastin WC; Mennear JH; Tennant RW; Stoll RE; Branstetter DG; Bucher JR; McCullough B; Binder RL; Spalding JW; Mahler JF
    Toxicol Pathol; 2001; 29 Suppl():60-80. PubMed ID: 11695563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Tg.AC (v-Ha-ras) transgenic mouse: nature of the model.
    Tennant RW; Stasiewicz S; Eastin WC; Mennear JH; Spalding JW
    Toxicol Pathol; 2001; 29 Suppl():51-9. PubMed ID: 11695562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of the hemizygous transgenic Tg.AC mouse for carcinogenicity testing of pharmaceuticals. I. Evidence for a confounding nonresponder phenotype.
    Weaver JL; Contrera JF; Rosenzweig BA; Thompson KL; Faustino PJ; Strong JM; Ellison CD; Anderson LW; Prasanna HR; Long-Bradley PE; Lin KK; Zhang J; Sistare FD
    Toxicol Pathol; 1998; 26(4):532-40. PubMed ID: 9715512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 26-Week dermal oncogenicity study evaluating pure trans-capsaicin in Tg.AC hemizygous mice (FBV/N).
    Chanda S; Erexson G; Frost D; Babbar S; Burlew JA; Bley K
    Int J Toxicol; 2007; 26(2):123-33. PubMed ID: 17454252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical application of representative multifunctional acrylates produced proliferative and inflammatory lesions in F344/N rats and B6C3F1 mice, and squamous cell neoplasms in Tg.AC mice.
    Doi AM; Hailey JR; Hejtmancik M; Toft JD; Vallant M; Chhabra RS
    Toxicol Pathol; 2005; 33(6):631-40. PubMed ID: 16176922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a transgenic mouse model for carcinogenesis bioassays: evaluation of chemically induced skin tumors in Tg.AC mice.
    Spalding JW; French JE; Tice RR; Furedi-Machacek M; Haseman JK; Tennant RW
    Toxicol Sci; 1999 Jun; 49(2):241-54. PubMed ID: 10416269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of lung lesions in female rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Tritscher AM; Mahler J; Portier CJ; Lucier GW; Walker NJ
    Toxicol Pathol; 2000; 28(6):761-9. PubMed ID: 11127289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.